Latest News & Features
Americas
Scott Alban of AstraZeneca outlines the company’s recent transformation aimed at breaking down barriers and the uncharted territories that it is eager to explore. 12 July 2018
Americas
Since joining Eli Lilly’s patent division nearly 20 years ago, Manisha Desai has worked on the procurement and enforcement of patents worldwide. 11 July 2018
Americas
A shift in Mexico’s examination practice on plant-related patents has caused legal uncertainty, say Daniel Eduardo López and Esteban Rodríguez of Clarke Modet & Co. 10 July 2018
Africa
A lack of blood donors and poor healthcare infrastructure inspired Temie Giwa-Tubosun to develop and deliver a life-saving app. LSIPR spoke to the founder of LifeBank. 10 July 2018
Big Pharma
Marie-Paule Kieny of the Drugs for Neglected Diseases Initiative is on a mission to remind stakeholders and governments that there is a moral imperative to pursue the fight against neglected diseases, as she tells LSIPR. 9 July 2018
Europe
A team at the University of Dundee has announced a major breakthrough in the understanding of Parkinson’s disease. LSIPR heard
more from Miratul Muqit and Daan van Aalten of the university’s school of life sciences. 6 July 2018
Africa
Glenda Gray, CEO and president of the South African Medical Research Council, tells LSIPR of the life-saving work she is undertaking and her ambitious goals to improve the South African healthcare landscape. 5 July 2018
Americas
Balancing a company’s duty to shareholders with the public responsibility to provide lifesaving treatments is a constant challenge, as Issi Rozen, chief business officer at the Broad Institute of MIT and Harvard, tells LSIPR. 4 July 2018
Americas
With his interests in IP development, biotechnology innovation policy, and R&D, Luiz Otávio Pimentel, president of Brazil’s patent office, tells LSIPR of his aims to improve the country’s IP performance. 3 July 2018
Europe
Brexit has created many uncertainties in the IP arena and the CEO of the UK Intellectual Property Office is urging stakeholders to speak up, so that the office isn’t the “lone voice” advocating the importance of IP. 2 July 2018